{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:56:23Z","timestamp":1792796183836,"version":"4.5.0"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.msard.2019.101452","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T12:46:19Z","timestamp":1571143579000},"page":"101452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases"],"prefix":"10.1016","volume":"37","author":[{"given":"Paula","family":"Wildner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2582-1708","authenticated-orcid":false,"given":"Mariusz","family":"Stasio\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Matysiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2019.101452_bib0001","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1191\/0961203303lu501oa","article-title":"The blood-brain barrier in systemic lupus erythematosus","volume":"12","author":"Abbott","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.msard.2019.101452_bib0002","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","article-title":"Neuro-Beh\u00e7et's disease: epidemiology, clinical characteristics, and management","volume":"8","author":"Al-Araji","year":"2009","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.msard.2019.101452_bib0003","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/ndt\/gfq356","article-title":"What nephrologists need to know about antiphospholipid syndrome","volume":"25","author":"Alchi","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0004","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0889-857X(21)00211-8","article-title":"Neurologic disease in Sjogren's syndrome: mononuclear inflammatory vasculopathy affecting central\/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis","volume":"19","author":"Alexander","year":"1993","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"5","key":"10.1016\/j.msard.2019.101452_bib0005","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1212\/WNL.44.5.899","article-title":"Anti-Ro (SS-A) autoantibodies in central nervous system disease associated with Sjogren's syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates","volume":"44","author":"Alexander","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101452_bib0006","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.clineuro.2013.07.026","article-title":"Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis","volume":"115","author":"Andreadou","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2019.101452_bib0007","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nature08990","article-title":"Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis","volume":"464","author":"Baranzini","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.msard.2019.101452_bib0008","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/WNL.45.2.384","article-title":"Frequency of antinuclear antibodies in multiple sclerosis","volume":"45","author":"Barned","year":"1995","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2019.101452_bib0009","first-page":"806","article-title":"Pulmonary fibrosis and lymphocytic alveolitis associated with triple antiphospholipid antibody positivity: a diagnostic puzzle","volume":"30","author":"Barnini","year":"2012","journal-title":"Clin, Exp, Rheumatol,"},{"key":"10.1016\/j.msard.2019.101452_bib0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/1352458514567216","article-title":"Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography","volume":"21","author":"Bennett","year":"2015","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0011","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1191\/0961203306lu2293rr","article-title":"Laboratory diagnosis and management challenges in the antiphospholipid syndrome","volume":"15","author":"Bertolaccini","year":"2006","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.msard.2019.101452_bib0012","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/STROKEAHA.116.016194","article-title":"Primary angiitis of the central nervous system: magnetic resonance imaging spectrum of parenchymal, meningeal, and vascular lesions at baseline","volume":"48","author":"Boulouis","year":"2017","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.msard.2019.101452_bib0013","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/art.38340","article-title":"Primary angiitis of the central nervous system: description of the first fifty-two adults enrolled in the French cohort of patients with primary vasculitis of the central nervous system","volume":"66","author":"Boysson","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.msard.2019.101452_bib0014","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/0961203310396748","article-title":"Antiphospholipid antibodies and the brain: a consensus report","volume":"20","author":"Brey","year":"2011","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.msard.2019.101452_bib0015","first-page":"103","article-title":"Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjogren's syndrome","volume":"31","author":"Brito-Zeron","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.msard.2019.101452_bib0016","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.0000000000000768","article-title":"Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity","volume":"83","author":"Browne","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0017","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.autrev.2018.01.001","article-title":"Diagnosis and management of neuromyelitis optica spectrum disorders - An update","volume":"17","author":"Bruscolini","year":"2018","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.msard.2019.101452_bib0018","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MAO.0000000000000501","article-title":"Cranial base manifestation of neurosarcoidosis: a review of 305 patients","volume":"36","author":"Carlson","year":"2014","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.msard.2019.101452_bib0019","article-title":"Optic chiasmand oculomotor nerves involvement in active multiple sclerosis","author":"Carra-Dalliere","year":"2018","journal-title":"J. Neuroradiol."},{"key":"10.1016\/j.msard.2019.101452_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00005792-199905000-00003","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European working party on systemic lupus erythematosus","volume":"78","author":"Cervera","year":"1999","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0021","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.msard.2019.101452_bib0022","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archneurol.2011.249","article-title":"Brain involvement in neuromyelitis optica spectrum disorders","volume":"68","author":"Chan","year":"2011","journal-title":"Arch. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2019.101452_bib0023","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(06)70572-5","article-title":"MRI and the diagnosis of multiple sclerosis: expanding the concept of \"no better explanation\u201d","volume":"5","author":"Charil","year":"2006","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.msard.2019.101452_bib0024","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.crad.2016.05.010","article-title":"MRI differential diagnosis of suspected multiple sclerosis","volume":"71","author":"Chen","year":"2016","journal-title":"Clin. Radiol."},{"issue":"5","key":"10.1016\/j.msard.2019.101452_bib0025","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/0961203317690242","article-title":"A critical analysis of the tools to evaluate neuropsychiatric lupus","volume":"26","author":"Clark","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.msard.2019.101452_bib0026","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MD.0b013e3181d5c6b4","article-title":"Spinal cord sarcoidosis. Clinical and laboratory profile and outcome of 31 patients in a case-control study","volume":"89","author":"Cohen-Aubert","year":"2010","journal-title":"Medicine"},{"key":"10.1016\/j.msard.2019.101452_bib0027","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/brain\/awg081","article-title":"Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process","volume":"126","author":"Confavreux","year":"2003","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0028","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/RCT.0b013e31829610e5","article-title":"3-T magnetic resonance angiography in primary angiitis of the central nervous system","volume":"37","author":"Cosottini","year":"2013","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.msard.2019.101452_bib0029","article-title":"Serology of lupus erythematosus: correlation between immunopathological features and clinical aspects","volume":"2014","author":"Cozzani","year":"2014","journal-title":"Autoimmune Dis."},{"issue":"5","key":"10.1016\/j.msard.2019.101452_bib0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/0961203316688784","article-title":"Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment","volume":"26","author":"de Amorim","year":"2017","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0031","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/rheumatology\/keu336","article-title":"Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes","volume":"54","author":"De Luna","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.msard.2019.101452_bib0032","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1468-1331.2006.01493.x","article-title":"Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force","volume":"13","author":"Deisenhammer","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2019.101452_bib0033","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0034","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.4238\/2014.July.2.8","article-title":"HLA-B51 subtypes in Turkish patients with Beh\u00e7et's disease and their correlation with clinical manifestations","volume":"13","author":"Demirseren","year":"2014","journal-title":"Genet. Mol. Res."},{"issue":"5","key":"10.1016\/j.msard.2019.101452_bib0035","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neurad.2019.06.001","article-title":"MRI features of demyelinating disease associated with anti-MOG antibodies in adults","volume":"46","author":"Den\u00e8ve","year":"2019","journal-title":"J. Neuroradiol."},{"key":"10.1016\/j.msard.2019.101452_bib0036","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/jnnp-2012-304695","article-title":"Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude","volume":"84","author":"Dobson","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"January 15","key":"10.1016\/j.msard.2019.101452_bib0037","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jns.2016.11.035","article-title":"The characteristics of spinal imaging in different types of demyelinating diseases","volume":"372","author":"Dumrikarnlert","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.msard.2019.101452_bib0038","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2016.12.001","article-title":"Central nervous system vasculitis in adults: an update","volume":"16","author":"Dutra","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.msard.2019.101452_bib0039","series-title":"Current Diagnosis & treatment: Rheumatology","article-title":"Microscopic polyangiitis","author":"Duvuru","year":"2013"},{"issue":"3\u20134","key":"10.1016\/j.msard.2019.101452_bib0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000445255","article-title":"The role of catheter angiography in the diagnosis of central nervous system vasculitis","volume":"5","author":"Edgell","year":"2016","journal-title":"Interv. Neurol."},{"key":"10.1016\/j.msard.2019.101452_bib0041","doi-asserted-by":"crossref","first-page":"18569","DOI":"10.1073\/pnas.1006980107","article-title":"Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms","volume":"107","author":"Faust","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.msard.2019.101452_bib0042","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.57.5.927","article-title":"Long-term follow-up of neurosarcoidosis","volume":"57","author":"Ferriby","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0043","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ana.21113","article-title":"Imaging correlates of axonal swelling in chronic multiple sclerosis brains","volume":"62","author":"Fisher","year":"2007","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2019.101452_bib0044","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","article-title":"Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.msard.2019.101452_bib0045","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/art.21041","article-title":"Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases","volume":"52","author":"Frances","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.msard.2019.101452_bib0046","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14737159.2017.1262260","article-title":"An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis","volume":"17","author":"Gastaldi","year":"2016","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"5","key":"10.1016\/j.msard.2019.101452_bib0047","first-page":"759","article-title":"Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis involving the central nervous system: case report and review of the literature","volume":"28","author":"Ghinoi","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"issue":"10","key":"10.1016\/j.msard.2019.101452_bib0048","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1007\/s00415-010-5611-7","article-title":"Primary angiitis of the CNS with pure spinal cord involvement: a case report","volume":"257","author":"Goertz","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2019.101452_bib0049","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/rheumatology\/keq408","article-title":"Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus","volume":"50","author":"Gono","year":"2011","journal-title":"Rheumatology (Oxford, UK)"},{"key":"10.1016\/j.msard.2019.101452_bib0050","series-title":"Current Diagnosis & treatment: Rheumatology","article-title":"Chapter 23. Antiphospholipid antibody syndrome","author":"Graf","year":"2013"},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0051","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.rdc.2017.06.006","article-title":"Central nervous system disease in antineutrophil cytoplasmic antibodies-associated vasculitis","volume":"43","author":"Graf","year":"2017","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.msard.2019.101452_bib0052","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.autrev.2014.12.004","article-title":"Churg\u2013Strauss syndrome","volume":"14","author":"Greco","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.msard.2019.101452_bib0053","first-page":"100","article-title":"A 60- year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland county, Western Norway","volume":"87","author":"Grytten","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.msard.2019.101452_bib0054","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1474-4422(11)70081-3","article-title":"Primary angiitis of the CNS","volume":"10","author":"Hajj-Ali","year":"2011","journal-title":"Lancet Neurol."},{"issue":"4 June","key":"10.1016\/j.msard.2019.101452_bib0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejim.2011.12.011","article-title":"Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet's disease in Tunisian patients","volume":"23","author":"Hamzaoui","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.msard.2019.101452_bib0056","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1191\/0961203304lu2024oa","article-title":"ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables","volume":"13","author":"Hanly","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.msard.2019.101452_bib0057","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2014.15","article-title":"Diagnosis and management of neuropsychiatric SLE","volume":"10","author":"Hanly","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.msard.2019.101452_bib0058","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2014.15","article-title":"Diagnosis and management of neuropsychiatric SLE.","volume":"10","author":"Hanly","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0059","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O","article-title":"A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus","volume":"42","author":"Hanly","year":"1999","journal-title":"Arthritis. Rheum."},{"issue":"10 October","key":"10.1016\/j.msard.2019.101452_bib0060","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/acr.23509","article-title":"Cerebrovascular events in systemic lupus erythematosus: results from an international inception cohort study","volume":"70","author":"Hanly","year":"2018","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.msard.2019.101452_bib0061","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/ard.2010.148502","article-title":"Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus","volume":"70","author":"Hanly","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.msard.2019.101452_bib0062","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.1780370418","article-title":"Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus","volume":"37","author":"Herranz","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.msard.2019.101452_bib0063","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/ar2184","article-title":"Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus","volume":"9","author":"Hirohata","year":"2007","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.msard.2019.101452_bib0064","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.93.8.1579","article-title":"Heart valve involvement (Libman\u2013Sacks endocarditis) in the antiphospholipid syndrome","volume":"93","author":"Hojnik","year":"1996","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.msard.2019.101452_bib0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/BOR.0b013e32834115f9","article-title":"Neurological involvement in Wegener's granulomatosis","volume":"23","author":"Holle","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"issue":"928","key":"10.1016\/j.msard.2019.101452_bib0066","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/pmj.79.928.81","article-title":"Migraine, memory loss, and \u201cmultiple sclerosis.\u201d neurological features of the antiphospholipid (Hughes\u2019) syndrome","volume":"79","author":"Hughes","year":"2003","journal-title":"Postgrad. Med. J."},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0067","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/1352458516687043","article-title":"Short segment myelitis as a first manifestation of neuromyelitis optica spectrum disorders","volume":"23","author":"Huh","year":"2017","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0068","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Beh\u00e7et's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.msard.2019.101452_bib0069","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1076\/jcen.21.2.251.931","article-title":"Neuropsychological deficits associated with antiphospholipid antibodies","volume":"21","author":"Jacobson","year":"1999","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.rdc.2017.06.003","article-title":"Central nervous system manifestations of systemic lupus erythematosus","volume":"43","author":"Jafri","year":"2017","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.msard.2019.101452_bib0071","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.msard.2019.101452_bib0072","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.msard.2019.101452_bib0073","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12271","article-title":"Neuromyelitis optica: clinical features, immunopathogenesis and treatment","volume":"176","author":"Jarius","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.msard.2019.101452_bib0074","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/rheumatology\/41.6.619","article-title":"The central nervous system in systemic lupus erythematous. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation","volume":"41","author":"Jennekens","year":"2002","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.msard.2019.101452_bib0075","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jaci.2017.10.003","article-title":"Biomarkers in connective tissue diseases","volume":"140","author":"Jog","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.msard.2019.101452_bib0076","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.24682","article-title":"Predictors of long-term disability accrual in relapse-onset multiple sclerosis","volume":"80","author":"Jokubaitis","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2019.101452_bib0077","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/01.wnl.0000267320.48939.d0","article-title":"CNS lupus: a study of 41 patients","volume":"69","author":"Joseph","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0078","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/aww350","article-title":"Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0079","first-page":"452","article-title":"The lung in the spectrum of antiphospholipid syndrome","volume":"31","author":"Kanakis","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.msard.2019.101452_bib0080","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1017\/S0022215100082426","article-title":"Deafness in sarcoidosis","volume":"90","author":"Kane","year":"1976","journal-title":"J. Laryngol. Otol."},{"issue":"11","key":"10.1016\/j.msard.2019.101452_bib0081","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101452_bib0082","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1007\/s00415-015-7842-0","article-title":"High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (19912010)","volume":"262","author":"Kingwell","year":"2015","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2019.101452_bib0083","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for Beh\u00e7et's disease and epistasis between HLA-B*51 and ERAP1","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.msard.2019.101452_bib0084","first-page":"1015","article-title":"CNS involvement in neuro-Behcet's syndrome: an MR study","volume":"20","author":"Kocer","year":"1999","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.msard.2019.101452_bib0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.59.2.120","article-title":"Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature","volume":"59","author":"Kovacs","year":"2000","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.msard.2019.101452_bib0086","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.59.2.120","article-title":"Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature","volume":"59","author":"Kovacs","year":"2000","journal-title":"Ann. Rheum. Dis."},{"issue":"10 March","key":"10.1016\/j.msard.2019.101452_bib0087","first-page":"e1007","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"issue":"2 June","key":"10.1016\/j.msard.2019.101452_bib0088","article-title":"Neuromyelitis optica spectrum disorder and Anti-MOG syndromes","volume":"7","author":"Lana-Peixoto","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.msard.2019.101452_bib0089","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2990.2011.01189.x","article-title":"Review: the architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis","volume":"37","author":"Lassmann","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.msard.2019.101452_bib0090","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2019.101452_bib0091","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2019.101452_bib0092","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2019.101452_bib0093","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.25146","article-title":"Central vein sign differentiates multiple sclerosis from central nervous system inflammatory vasculopathies","volume":"83","author":"Maggi","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2019.101452_bib0094","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/0961203316643170","article-title":"Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus","volume":"25","author":"Magro-Checa","year":"2016","journal-title":"Lupus"},{"issue":"4 November","key":"10.1016\/j.msard.2019.101452_bib0095","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.rdc.2017.06.001","article-title":"Primary angiitis of the central nervous system","volume":"43","author":"Mandal","year":"2017","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0096","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/03009749209095089","article-title":"Magnetic resonance imaging of the brain in patients with primary Sjogren's syndrome","volume":"21","author":"Manthorpe","year":"1992","journal-title":"Scand. J. Rheumatol."},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0097","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rdc.2017.06.002","article-title":"Neurologic manifestations of primary sj\u00f6gren syndrome","volume":"43","author":"Margaretten","year":"2017","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"8","key":"10.1016\/j.msard.2019.101452_bib0098","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/keq111","article-title":"Central nervous system involvement in Sjogren's syndrome: unusual, but not unremarkable\u2013clinical, serological characteristics and outcomes in a large cohort of Italian patients","volume":"49","author":"Massara","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.msard.2019.101452_bib0099","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/1352458507085801","article-title":"Argentine patagonia: prevalence and clinical features of multiple sclerosis","volume":"14","author":"Melcon","year":"2008","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L","article-title":"A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus","volume":"42","author":"Menon","year":"1999","journal-title":"Arthritis. Rheum."},{"key":"10.1016\/j.msard.2019.101452_bib0101","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1212\/01.WNL.0000165959.98370.D5","article-title":"Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus","volume":"64","author":"Mikdashi","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101452_bib0102","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1474-4422(07)70243-0","article-title":"Primary-progressive multiple sclerosis","volume":"6","author":"Miller","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2019.101452_bib0103","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller","year":"2008","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2019.101452_bib0104","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0b013e318181e097","article-title":"Biopsy findings in primary angiitis of the central nervous system","volume":"33","author":"Miller","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.msard.2019.101452_bib0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"2 February","key":"10.1016\/j.msard.2019.101452_bib0106","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458517751049","article-title":"ECTRIMS\/EAN guideline on the pharmacological treatment of people with multiple sclerosis","volume":"24","author":"Montalban","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2019.101452_bib0107","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1212\/WNL.44.1.11","article-title":"The British Isles survey of multiple sclerosis in twins","volume":"44","author":"Mumford","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101452_bib0108","first-page":"1580","article-title":"Churg-Strauss syndrome","volume":"70","author":"Murthy","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2019.101452_bib0109","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ncl.2009.09.004","article-title":"Neurologic manifestations of systemic lupus erythematosus in children and adults","volume":"28","author":"Muscal","year":"2010","journal-title":"Neurol. Clin."},{"issue":"3 August","key":"10.1016\/j.msard.2019.101452_bib0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10238-016-0430-5","article-title":"The antiphospholipid syndrome: from pathophysiology to treatment","volume":"17","author":"Negrini","year":"2017","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.msard.2019.101452_bib0111","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1016\/j.lpm.2011.12.017","article-title":"Neurosarcoidosis: clinical manifestations, diagnosis and treatment","volume":"41","author":"Nozaki","year":"2012","journal-title":"Presse. Med."},{"issue":"2 March","key":"10.1016\/j.msard.2019.101452_bib0112","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1468-3083.2001.00251.x","article-title":"The multiple faces of Beh\u00e7et's disease and its aetiological factors","volume":"15","author":"Onder","year":"2001","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.msard.2019.101452_bib0113","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","article-title":"Biorepository for neuromyelitis, demographic and clinical features of neuromyelitis optica: a review","volume":"21","author":"Pandit","year":"2015","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2019.101452_bib0114","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.msard.2019.101452_bib0115","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s10067-012-2019-z","article-title":"Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjogren's syndrome","volume":"31","author":"Pasoto","year":"2012","journal-title":"Clin. Rheumatol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2019.101452_bib0116","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaut.2012.01.003","article-title":"Peripheral neuropathies in Sjogren's syndrome: a critical update on clinical features and pathogenetic mechanisms","volume":"39","author":"Pavlakis","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.msard.2019.101452_bib0117","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/qjmed\/hcp042","article-title":"Presentations and outcomes of neurosarcoidosis: a study of 54 cases","volume":"102","author":"Pawate","year":"2009","journal-title":"QJM"},{"issue":"7 July","key":"10.1016\/j.msard.2019.101452_bib0118","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/qjmed\/hcp042","article-title":"Presentations and outcomes of neurosarcoidosis: a study of 54 cases","volume":"102","author":"Pawate","year":"2009","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0119","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1352458515591069","article-title":"Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging","volume":"22","author":"Pekcevik","year":"2016","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.clinimag.2015.07.027","article-title":"What do we know about brain contrast enhancement patterns in neuromyelitis optica?","volume":"40","author":"Pekcevik","year":"2016","journal-title":"Clin. Imaging"},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0121","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMct1101691","article-title":"Fingolimod for multiple sclerosis","volume":"366","author":"Pelletier","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0122","doi-asserted-by":"crossref","first-page":"524","DOI":"10.7326\/0003-4819-106-4-524","article-title":"The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level","volume":"106","author":"Petri","year":"1987","journal-title":"Ann. Intern. Med."},{"issue":"7 August","key":"10.1016\/j.msard.2019.101452_bib0123","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.msard.2019.101452_bib0124","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11926-013-0397-0","article-title":"Renal involvement in antiphospholipid syndrome","volume":"16","author":"Pons-Estel","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.msard.2019.101452_bib0125","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1017\/S0317167100009380","article-title":"Prevalence of multiple sclerosis in Canada: a systematic review","volume":"35","author":"Poppe","year":"2008","journal-title":"Can. J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0126","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2019.101452_bib0127","first-page":"470","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyteglycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"MultScler. J."},{"key":"10.1016\/j.msard.2019.101452_bib0128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/096120339600500207","article-title":"Brain calcification in patients with cerebral lupus","volume":"5","author":"Raymond","year":"1996","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0129","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2362.2010.02263.x","article-title":"Neurological manifestations of antiphospholipid syndrome","volume":"40","author":"Rodrigues","year":"2010","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.msard.2019.101452_bib0130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/jaut.2000.0367","article-title":"Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients","volume":"14","author":"Roussel","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.msard.2019.101452_bib0131","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ncl.2012.09.010","article-title":"Neuromyelitis optica: clinical manifestations and neuroimaging features","volume":"31","author":"Sahraian","year":"2013","journal-title":"Neurol. Clin."},{"issue":"5","key":"10.1016\/j.msard.2019.101452_bib0132","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ana.21226","article-title":"Primary central nervous system vasculitis: analysis of 101 patients","volume":"62","author":"Salvarani","year":"2007","journal-title":"Ann. Neurol."},{"issue":"21","key":"10.1016\/j.msard.2019.101452_bib0133","doi-asserted-by":"crossref","first-page":"e738","DOI":"10.1097\/MD.0000000000000738","article-title":"An update of the mayo clinic cohort of patients with adult primary central nervous system vasculitis: description of 163 patients","volume":"94","author":"Salvarani","year":"2015","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.msard.2019.101452_bib0134","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/1756-185X.13046","article-title":"Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: a retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"20","author":"Shimojima","year":"2017","journal-title":"Int. J. Rheum, Dis,"},{"issue":"7","key":"10.1016\/j.msard.2019.101452_bib0136","first-page":"1344","article-title":"Features associated with epilepsy in the antiphospholipid syndrome","volume":"31","author":"Shoenfeld","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.msard.2019.101452_bib0137","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semarthrit.2009.08.005","article-title":"Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus","volume":"40","author":"Sibbitt","year":"2010","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.msard.2019.101452_bib0138","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/jnnp.2011.240432","article-title":"Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis","volume":"82","author":"Simpson","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1 February","key":"10.1016\/j.msard.2019.101452_bib0139","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ncl.2017.08.014","article-title":"Common clinical and imaging conditions misdiagnosed as multiple sclerosis: a current approach to the differential diagnosis of multiple sclerosis","volume":"36","author":"Siva","year":"2018","journal-title":"Neurol. Clin."},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0140","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00415-009-0145-6","article-title":"The spectrum of nervous system involvement in Behcet's syndrome and its differential diagnosis","volume":"256","author":"Siva","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2019.101452_bib0141","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2214\/ajr.182.2.1820289","article-title":"Imaging manifestations of neurosarcoidosis","volume":"182","author":"Smith","year":"2004","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.msard.2019.101452_bib0142","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1212\/WNL.0000000000003152","article-title":"The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study","volume":"87","author":"Solomon","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101452_bib0143","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1212\/WNL.0b013e318259e1b2","article-title":"\u201cUndiagnosing\u201d multiple sclerosis: the challenge of misdiagnosis in MS","volume":"78","author":"Solomon","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101452_bib0144","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11910-013-0403-y","article-title":"Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention","volume":"13","author":"Solomon","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"5","key":"10.1016\/j.msard.2019.101452_bib0145","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrneurol.2013.41","article-title":"The utility of cerebrospinal fluid analysis in patients with multiple sclerosis","volume":"9","author":"Stangel","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2019.101452_bib0146","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrneurol.2013.41","article-title":"The utility of cerebrospinal fluid analysis in patients with multiple sclerois","volume":"9","author":"Stangel","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2019.101452_bib0147","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archneur.1985.04060080095022","article-title":"Sarcoidosis and its neurological manifestations","volume":"42","author":"Stern","year":"1985","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2019.101452_bib0148","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5114\/fn.2014.43790","article-title":"Primary angiitis of the central nervous system: a study of histopathological patterns and review of the literature","volume":"52","author":"Suri","year":"2014","journal-title":"Folia Neuropathol."},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0149","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11926-001-0032-3","article-title":"Neurologic manifestations of the antiphospholipid syndrome","volume":"3","author":"Tanne","year":"2001","journal-title":"Curr. Rheumatol. Rep,"},{"key":"10.1016\/j.msard.2019.101452_bib0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/NRL.0b013e3181c92a72","article-title":"Neurosarcoidosis. Presentations and management","volume":"16","author":"Terushkin","year":"2010","journal-title":"Neurologist"},{"key":"10.1016\/j.msard.2019.101452_bib0151","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2019.101452_bib0152","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/brain\/awv105","article-title":"Defining high, medium and low impact prognostic factors for developing multiple sclerosis","volume":"138","author":"Tintore","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.msard.2019.101452_bib0153","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3174\/ajnr.A4539","article-title":"Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis","volume":"37","author":"Traboulsee","year":"2016","journal-title":"AJNR Am. J. Neuroradiology"},{"key":"10.1016\/j.msard.2019.101452_bib0154","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01290-2016","article-title":"Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013","volume":"49","author":"Ungprasert","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0155","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.rdc.2017.06.008","article-title":"Neurosarcoidosis","volume":"43","author":"Ungprasert","year":"2017","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.msard.2019.101452_bib0156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2010.08.001","article-title":"Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis","volume":"41","author":"Unterman","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.msard.2019.101452_bib0157","series-title":"International Neurology","first-page":"88","article-title":"Behcet's syndrome and nervous system involvement","author":"Uygunoglu","year":"2016"},{"key":"10.1016\/j.msard.2019.101452_bib0158","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25004","article-title":"Myelopathy in Behc\u00b8 et's disease: the bagel sign","author":"Uygunoglu","year":"2017","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2019.101452_bib0159","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jocn.2012.12.022","article-title":"Neuromyelitis optica: concept, immunology and treatment","volume":"21","author":"Uzawa","year":"2014","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0160","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/ene.12898","article-title":"Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands","volume":"23","author":"van Pelt","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2019.101452_bib0161","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/1531-8249(199911)46:5<747::AID-ANA10>3.0.CO;2-4","article-title":"Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability","volume":"46","author":"van Waesberghe","year":"1999","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2019.101452_bib0162","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejrad.2010.06.024","article-title":"Brain MRI abnormalities in neuromyelitis optica","volume":"80","author":"Wang","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.msard.2019.101452_bib0163","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrneurol.2015.157","article-title":"Evidence-based guidelines: magnims consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients","volume":"11","author":"Wattjes","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2019.101452_bib0164","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101452_bib0165","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2019.101452_bib0166","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.msard.2019.101452_bib0167","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.msard.2019.101452_bib0168","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11926-016-0568-x","article-title":"Non-stroke central neurologic manifestations in antiphospholipid syndrome","volume":"18","author":"Yelnik","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0169","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458513495581","article-title":"\u201cBright spotty lesions\u201d on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis","volume":"20","author":"Yonezu","year":"2014","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2019.101452_bib0170","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1212\/WNL.0000000000004796","article-title":"Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses","volume":"90","author":"Zalewski","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2019.101452_bib0171","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/jnnp-2016-314738","article-title":"Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders","volume":"88","author":"Zalewski","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2019.101452_bib0172","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.semarthrit.2006.11.003","article-title":"Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome","volume":"36","author":"Zandman-Goddard","year":"2007","journal-title":"Sem. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.msard.2019.101452_bib0173","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1212\/NXI.0000000000000110","article-title":"Aquaporin-4 autoimmunity","volume":"2","author":"Zekeridou","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2019.101452_bib0174","series-title":"Multiple Sclerosis & Cerebrospinal Fluid","first-page":"1","author":"Zettl","year":"2005"},{"key":"10.1016\/j.msard.2019.101452_bib0175","first-page":"163","volume":"36","author":"Zeydan","year":"2018"},{"issue":"1\u20132","key":"10.1016\/j.msard.2019.101452_bib0176","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jns.2014.08.010","article-title":"Neurological antiphospholipid syndrome: clinical, neuroimaging, and pathological characteristics","volume":"346","author":"Zhu","year":"2014","journal-title":"J. Neurol. Sci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819304407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819304407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:46:15Z","timestamp":1761900375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034819304407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":176,"alternative-id":["S2211034819304407"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2019.101452","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2019.101452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101452"}}